Background During the 2002 West Nile virus epidemic in the United States, patients were
identified whose West Nile virus illness was temporally associated with the receipt of …

Context.—Differentiating individuals with early human immunodeficiency virus 1 (HIV-1)
infection from those infected for longer periods is difficult but important for estimating HIV …

Background Testing of blood donors for human immunodeficiency virus type 1 (HIV-1) and
hepatitis C virus (HCV) RNA by means of nucleic acid amplification was introduced in the …

We report unbiased metagenomic detection of chikungunya virus (CHIKV), Ebola virus (EBOV),
and hepatitis C virus (HCV) from four human blood samples by MinION nanopore …

Importance People who have been infected with or vaccinated against SARS-CoV-2 have
reduced risk of subsequent infection, but the proportion of people in the US with SARS-CoV-2 …

… We referred to the report by Stramer and coworkers 23 to ascertain the number of HIV-1 and
HCV MP-NAT-positive, antibody-negative donations (referred to as MP-NAT yield cases in …

Zika virus (ZIKV) is spreading rapidly into regions around the world where other flaviviruses,
such as dengue virus (DENV) and West Nile virus (WNV), are endemic. Antibody-…

BACKGROUND: Emerging infections have been identified as a continuing threat to human
health. Many such infections are known to be transmissible by blood transfusion, while others …

BACKGROUND: Nucleic acid testing (NAT) for human immunodeficiency virus (HIV) and
hepatitis C virus (HCV) was introduced for blood donation screening in the United States in …

Appropriate use and interpretation of serological tests for assessments of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure, infection and potential immunity …